1. Home
  2. ANAB vs JJSF Comparison

ANAB vs JJSF Comparison

Compare ANAB & JJSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$53.61

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo J & J Snack Foods Corp.

JJSF

J & J Snack Foods Corp.

HOLD

Current Price

$77.71

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
JJSF
Founded
2005
1971
Country
United States
United States
Employees
N/A
1800
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
ANAB
JJSF
Price
$53.61
$77.71
Analyst Decision
Buy
Strong Buy
Analyst Count
12
2
Target Price
$71.67
$140.00
AVG Volume (30 Days)
818.3K
195.2K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
3.67%
EPS Growth
91.02
N/A
EPS
N/A
0.13
Revenue
$234,603,000.00
$1,022,038,000.00
Revenue This Year
N/A
$0.30
Revenue Next Year
$52.14
$1.70
P/E Ratio
N/A
$588.00
Revenue Growth
157.01
N/A
52 Week Low
$17.11
$68.87
52 Week High
$73.30
$129.24

Technical Indicators

Market Signals
Indicator
ANAB
JJSF
Relative Strength Index (RSI) 44.82 54.09
Support Level $52.32 $72.93
Resistance Level $57.70 $78.56
Average True Range (ATR) 4.55 2.19
MACD -0.98 0.10
Stochastic Oscillator 24.72 74.10

Price Performance

Historical Comparison
ANAB
JJSF

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.

Share on Social Networks: